ReachMD
Be part of the knowledge.™
Popular
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Against the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Medical Industry FeatureAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
The Network Effect: Analyzing Brain Structures to Treat Depression
Medical Industry FeatureThe Network Effect: Analyzing Brain Structures to Treat Depression
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Inflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Medical Industry FeatureInflammatory Pathways in Severe Asthma: Focus on Mucus Plugs
Deep Learner: Building AI to Improve Cardiovascular Care
Medical Industry FeatureDeep Learner: Building AI to Improve Cardiovascular Care
Programs
No effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
ACC Action CenterNo effect on the primary endpoint with SGLT2i post-MI, but significant effect on HF hospitalizations
Ultrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
CME/CEUltrasound Renal Denervation: Interdisciplinary Approach to Better Patient Outcomes
0.50 creditsAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
Medical Industry FeatureAgainst the Odds: Improving Survival for Children with Pulmonary Vein Stenosis
More than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
ACC Action CenterMore than 70% lowering of triglycerides with APOC3 RNAi in patients with severe hypertriglyceridemia
Addressing Treatment Gaps Among Patients with MDS-Associated Anemia
Medical Industry FeatureAddressing Treatment Gaps Among Patients with MDS-Associated Anemia
Self-assessment on statin eligibility without prescription using a web app
ACC Action CenterSelf-assessment on statin eligibility without prescription using a web app
Clinical Practice
Stopping aspirin after 1 month DAPT in ACS patients after stenting
ACC Action CenterStopping aspirin after 1 month DAPT in ACS patients after stenting
Pruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
CME/CEPruritus Cases From the Field: Real-World Perspectives on Managing CKD-aP
0.25 creditsManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
Clinician's RoundtableManaging AKI in ICU Trauma Patients: The Role of a Multidisciplinary Team
No improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
ACC Action CenterNo improvements in CV outcomes at 90 days with human ApoA-1 infusions post-MI
Unveiling the Numerous Benefits of RTA Prefilled Syringes
Clinician's RoundtableUnveiling the Numerous Benefits of RTA Prefilled Syringes
Delivering Transformation: Reducing Maternal Mortality Through Systemic Change
Medical Industry FeatureDelivering Transformation: Reducing Maternal Mortality Through Systemic Change
Doctors Lounge
KOL Knockout™: Cancer Pain Management Edition
CME/CEKOL Knockout™: Cancer Pain Management Edition
1.50 creditsLet’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
CME/CELet’s Rewind: Recognizing NAFLD/NASH in the Primary Care Clinic
0.25 creditsDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
NeuroFrontiersDisparities in DMT Access: Women with MS Are Less Likely to Receive Treatment
Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden
Project Oncology®Poster Pearl: Imaging-Based Localization for MCED Tests Yields Lower Diagnostic Burden
25 Must-Know Medical Abbreviations
Brain Games25 Must-Know Medical Abbreviations
Key Considerations for CGM Use in Older Adults with T1D
Diabetes DiscourseKey Considerations for CGM Use in Older Adults with T1D
CME
Applying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
CME/CEApplying SDM to Personalize Treatment Discussions on Recurrence Risk Reduction in Patients with Early-Stage Melanoma
0.25 creditsUnderstanding the Recent Advances in IgAN
CME/CEUnderstanding the Recent Advances in IgAN
0.25 creditsExtending Treatment Durability With Next-Generation Neovascular AMD Therapies
CME/CEExtending Treatment Durability With Next-Generation Neovascular AMD Therapies
0.50 creditsImproving Outcomes in Patients with RVO: Tailoring Treatment
CME/CEImproving Outcomes in Patients with RVO: Tailoring Treatment
1.00 credits- CME/CE Meeting
May 25, 2024
13:45 - 14:45 CEST
Advancing IgAN Care: Expert Strategies for Transformative Patient Outcomes
Efficacy Data for Bispecific Antibodies in RRMM
MinuteCE®Efficacy Data for Bispecific Antibodies in RRMM
1.00 program credits
Industry Feature
Mechanism of Disease: Immunoglobulin A Nephropathy
Medical Industry FeatureMechanism of Disease: Immunoglobulin A Nephropathy
Confronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Medical Industry FeatureConfronting the Complexities of Reaching LDL-C Thresholds in Patients with Primary Hyperlipidemia
Advancing the Science of Anemia Due to CKD
Medical Industry FeatureAdvancing the Science of Anemia Due to CKD
Prevalence and Burden of Anemia of CKD
Medical Industry FeaturePrevalence and Burden of Anemia of CKD
Identifying Appropriate Patients for Acute Seizure Treatment
Medical Industry FeatureIdentifying Appropriate Patients for Acute Seizure Treatment
Diving into a Treatment for Seizure Clusters Through Patient Case Studies
Medical Industry FeatureDiving into a Treatment for Seizure Clusters Through Patient Case Studies
